Showing results (11-20 of 179) with videos related to
Sort By:
Pageof 18
Current Opinion in Pharmacology|April 25, 2021
Current status of hepatitis deltaMargarita Papatheodoridi, George V PapatheodoridisWorld Journal of Gastroenterology|November 17, 2012
Current progress in the treatment of chronic hepatitis CAlexandra Alexopoulou, George V PapatheodoridisLiver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Is hepatitis delta underestimated?Margarita Papatheodoridi, George V PapatheodoridisLiver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?Jiannis Vlachogiannakos, George V PapatheodoridisLiver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
New epidemiology of hepatitis deltaJiannis Vlachogiannakos, George V PapatheodoridisLiver International : Official Journal of the International Association for the Study of the Liver|December 23, 2014
Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?Jiannis Vlachogiannakos, George V PapatheodoridisEuropean Journal of Internal Medicine|November 8, 2023
Natural history of metabolic dysfunction-associated steatotic liver diseaseVasileios Lekakis, George V PapatheodoridisCurrent Opinion in Molecular Therapeutics|September 8, 2006
Drug evaluation: LB-80380--a novel phosphonate nucleoside for the potential treatment of HBV infectionGeorge V Papatheodoridis, Spilios ManolakopoulosFuture Microbiology|September 25, 2008
Resistance issues in treating chronic hepatitis BGeorge V Papatheodoridis, Melanie DeutschExpert Opinion on Emerging Drugs|December 2, 2004
Emerging treatments in chronic hepatitis BStephanos J Hadziyannis, George V PapatheodoridisPageof 18